Farideh Razi

Dr. Farideh Razi


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SHShaghayegh Hosseinkhani
Shaghayegh Hosseinkhani
BABabak Arjmand
Babak Arjmand
ADArezou Dilmaghani-Marand
Arezou Dilmaghani-Marand
SFSahar Mohammadi Fateh
Sahar Mohammadi Fateh
HDHojat Dehghanbanadaki
Hojat Dehghanbanadaki
FRFarideh Razi
Farideh Razi
Diabetes is a common chronic disease affecting millions of people worldwide. It underlies various complications and imposes many costs on individuals and society. Discovering early diagnostic biomarkers takes excellent insight into preventive plans and the best use of interventions. Therefore, in the present study, we aimed to evaluate the association between the level of amino acids and acylcarnitines and diabetes to develop diabetes predictive models. Using the targeted LC–MS/MS technique, we analyzed fasting plasma samples of 206 cases and 206 controls that were matched by age, sex, and BMI. The association between metabolites and diabetes was evaluated using univariate and multivariate regression analysis with adjustment for systolic and diastolic blood pressure and lipid profile. To deal with multiple comparisons, factor analysis was used. Participants' average age and BMI were 61.6 years, 28.9 kg/m2, and 55% were female. After adjustment, Factor 3 (tyrosine, valine, leucine, methionine, tryptophan, phenylalanine), 5 (C3DC, C5, C5OH, C5:1), 6 (C14OH, C16OH, C18OH, C18:1OH), 8 (C2, C4OH, C8:1), 10 (alanine, proline) and 11 (glutamic acid, C18:2OH) were positively associated with diabetes. Inline, factor 9 (C4DC, serine, glycine, threonine) and 12 (citrulline, ornithine) showed a reverse trend. Some amino acids and acylcarnitines were found as potential risk markers for diabetes incidents that reflected the disturbances in the several metabolic pathways among the diabetic population and could be targeted to prevent, diagnose, and treat diabetes.

4 November 2022 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
NHNastaran Hadizadeh
Nastaran Hadizadeh
DBDiba Bagheri
Diba Bagheri
MSMehdi Shamsara
Mehdi Shamsara
Michael R. HamblinMichael R. Hamblin
Michael R. Hamblin
AFAbbas Farmany
Abbas Farmany
EHEhsan Hashemi
Ehsan Hashemi
The main goals of medicine consist of early detection and effective treatment of different diseases. In this regard, the rise of exosomes as carriers of natural biomarkers has recently attracted a lot of attention and managed to shed more light on the future of early disease diagnosis methods. Here, exosome biogenesis, its role as a biomarker in metabolic disorders, and recent advances in state-of-art technologies for exosome detection and isolation will be reviewed along with future research directions and challenges regarding the manipulation and genetic engineering of exosomes for potential in vitro and in vivo disease diagnosis approaches.

31 March 2017 in Journal of Diabetes & Metabolic Disorders
Verified
Journal Article
Open access
PDF file
NRNajmeh Rahimi
Najmeh Rahimi
FRFarideh Razi
Farideh Razi
ENEnsieh Nasli-Esfahani
Ensieh Nasli-Esfahani
MQMostafa Qorbani
Mostafa Qorbani
NSNooshin Shirzad
Nooshin Shirzad
BLBagher Larijani
Bagher Larijani
The prevalence of gestational diabetes mellitus (GDM) is increasing globally which is associated with various side effects for mothers and fetus. It seems

17 February 2017 in Journal of Diabetes & Metabolic Disorders
Verified
Journal Article
Open access
PDF file
ENEnsieh Nasli-Esfahani
Ensieh Nasli-Esfahani
FFFarshad Farzadfar
Farshad Farzadfar
MKMarjan Kouhnavard
Marjan Kouhnavard
RGRobabeh Ghodssi-Ghassemabadi
Robabeh Ghodssi-Ghassemabadi
AKAlireza Khajavi
Alireza Khajavi
BLBagher Larijani
Bagher Larijani
Backgrounds Diabetes is one of the most common metabolic disorders worldwide. This study aim was to provide detail analysis of diabetes research output and its trend in Iran as well as in the world and compare them. Methods Data was retrieved from PubMed database using a suitable search strategy and application of proper operator “AND”, “OR” and “NOT”. All English documents published from 2008 to 2012 were included. Meeting abstract, letter to the editor, guidelines, consensus and reviews were excluded. Obtained documents for Iran and world were categorized in eleven groups including diabetes management, education, paediatrics, nutrition, epidemiology, diabetes complications, stem cells, gestational diabetes mellitus (GDM), psychiatrics, genetics and prevention and were compared. Results Total number of DM publications was 59513 for world and 648 for Iran. Trend of DM publications was increasing during the 5 years with a growth rate of 22.5% for world and 23.4% for Iran. Contribution of Iran in the world diabetes output reached 1.08 in 2012. The most and the least number of DM documents were related to complications and preventions, respectively both in Iran and the world. Three leading countries with highest proportion of RCTs (randomized clinical trial) to their total DM publications were Italy, Germany and Iran. Conclusion The most number of diabetes research was in the field of diabetes complication, management and genetics in the world as well as in Iran. During the 5-year period, despite of the world sanctions against Iran, diabetes research trend was increasing in Iran relatively parallel to the world research and sanction had no significant effect on Iran.

1 December 2015 in Journal of Diabetes & Metabolic Disorders
Verified
Journal Article
Open access
PDF file
MMMohsen Mehrabzadeh
Mohsen Mehrabzadeh
PPParvin Pasalar
Parvin Pasalar
MKMostafa Karimi
Mostafa Karimi
MAMaryam Abdollahi
Maryam Abdollahi
MDMaryam S Daneshpour
Maryam S Daneshpour
FRFarideh Razi
Farideh Razi
Diabetic nephropathy (DN) is one of the leading causes of death in patients with type 2 diabetes mellitus (T2DM). Several genome-wide association studies h

1 January 2017 in Gene
Verified
Journal Article
Closed access
NSNegin Soroush
Negin Soroush
MRMania Radfar
Mania Radfar
AHArmita Kakavand Hamidi
Armita Kakavand Hamidi
MAMohammad Abdollahi
Mohammad Abdollahi
MQMostafa Qorbani
Mostafa Qorbani
MAMahsa M. Amoli
Mahsa M. Amoli